leisure time -WSS

leisure time

author：hotspot 2025-10-01 00:30:41 - browse：36

Illumina said Monday afternoon that its board of directors had approved a spin-off of its cancer test subsidiary Grail, signaling that a nearly four-year-long, $8 billion saga will finally draw to a close this month.

Shares in the newly independent Grail are expected to be distributed on June 24, Illumina said in a statement. Illumina will retain a 14.5% stake in the company, which will trade under the ticker $GRAL.

It’s the second time Illumina has spun off Grail, which initially began as a unit within the DNA sequencing giant in 2015. Illumina turned it into an independent company the following year but then agreed to reacquire it for $8 billion in September 2020.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： A preacher's new calling: Diversifying neuroscience research

explore

WSS

Biden will tout long

NYC plans to house migrants on an island in the East River

Fauci's latest grilling in Congress: 9 hours, behind closed doors

In medicine, common shorthands can shortchange care

NYC plans to house migrants on an island in the East River

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Medical records are filled with copy

Male doctors called my cancer incurable. A female doctor showed it wasn't

Drug repurposing or repositioning? The language matters

Life science postdocs should get big pay hike, NIH panel says

Jerome Adams on the need for new antivirals for Covid

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Medicare proposal to cover medical devices draws a mixed reaction

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

23andMe had bad news about my health. I wish a person had delivered it

FDA early review: GLP

entertainment

Does Paxlovid work in people vaccinated against Covid

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Study suggests new cause of Down syndrome: cells linked to aging

'The Exorcist' director William Friedkin dead at 87

Arena BioWorks launches in Cambridge to speed drug discovery

Physician assistants need a new name. Here's what it should be

focus

explore

explore

entertainment